Skip to main content

Abstract

Although anesthesiologists are adept at caring for the perioperative patient and the many physiologic aberrations resulting from surgery and anesthesia, management of perioperative pharmacology presents its own diverse set of challenges. Pharmacologic considerations for the perioperative period include the impact of (1) variable responses based on the patient’s genotype and/or phenotype, (2) preexisting diseases and drug therapies, (3) interactions with herbal supplementation, and (4) the physiologic changes associated with anesthesia. Many surgical patients are on chronic medications for comorbidities unrelated to the diagnosis that brought them to the OR. Anesthesiologists must be aware of both the effects of withdrawing chronic medications and the potential for interactions between “home” medications and the many drugs administered during the perioperative period. In addition to pharmacologic interactions, patient-specific factors like weight and genetic makeup will also impact the anesthetic plan. This chapter will discuss these factors, as well as anesthetic implications of commonly used medications, including herbal supplements. The side effects of nicotine and other aspects of cigarette smoking will also be discussed due to its prevalence and important anesthetic implications. Finally, the impact of anesthesia and surgery on human physiology and subsequent effects on drug metabolism will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pelosi P. Perioperative management of obese patients. Best Pract Res Clin Anesthesiol. 2010;24(2):211.

    Article  Google Scholar 

  2. El-Orbany M, Woehick HJ. Difficult mask ventilation. Anesth Analg. 2009;109(6):1870–80.

    Article  PubMed  Google Scholar 

  3. Schug SA. Postoperative pain management of the obese patient. Best Pract Res Clin Anesthesiol. 2011;25(1):73–81.

    Article  CAS  Google Scholar 

  4. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004;58(2):119–33.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Servin F, Farinotti R, Haberer JP, Desmonts JM. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology. 1993;78:657–65.

    Article  CAS  PubMed  Google Scholar 

  6. Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg. 2011;113(1):57–62.

    Article  CAS  PubMed  Google Scholar 

  7. Baerdemaeker L. Pharmacokinetics in obese patients. Contin Educ Anesth Crit Care Pain. 2004;4:152–5.

    Article  Google Scholar 

  8. Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The effects of cisatracurium on morbidly obese women. Anesth Analg. 2004;99:1090.

    Article  CAS  PubMed  Google Scholar 

  9. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS. Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth Analg. 1996;83:1076–80.

    CAS  PubMed  Google Scholar 

  10. Hodgkin WE, Giblett ER. Complete pseudocholinesterase deficiency: genetic and immunologic characterization. J Clin Investig. 1965;44(3):486–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Dong-Chan K. Malignant hyperthermia. Kor J Anesthesiol. 2012;63(5):391–401.

    Article  Google Scholar 

  12. Crews KR, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of Cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther. 2012;91(2):321–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Liem EB, Lin CM, Suleman MUI, Doufas AG, Gregg RG, Veauthier JM, et al. Anesthetic requirement is increased in redheads. Anesthesiology. 2004;01:279–83.

    Article  Google Scholar 

  14. Fortier MA, Tan ET, Mayes LC, Wahi A, Rosenbaum A, Strom S, Santistevan R, Kain ZN. Ethnicity and parental report of postoperative behavioral changes in children. Paediatr Anaesth. 2012;23:422–8.

    Article  PubMed  Google Scholar 

  15. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. NCHS data brief, no 48. Hyattsville, MD: National Center for Health stats 2010.

    Google Scholar 

  16. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;28;353(4):349–61.

    Google Scholar 

  17. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a metaanalysis. Am J Med. 2003;114:742–52.

    Article  CAS  PubMed  Google Scholar 

  18. Hayashi Y, Maze M. Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth. 1993;71(8):108–18.

    Google Scholar 

  19. Neideen T, Lam M, Brasel KJ. Preinjury beta blockers are associated with increased mortality in geriatric trauma patients. J Trauma. 2008;65:1016–20.

    Article  CAS  PubMed  Google Scholar 

  20. Metz S, Klein C, Morton N. Rebound hypertension after discontinuation of transdermal clonidine therapy. Am J Med. 1987;82:17.

    Google Scholar 

  21. Kataja JHK, Kaukinen S, Viinamaki OVK, et al. Hemodynamic and hormonal changes in patients pretreated with captopril for surgery of the abdominal aorta. J Cardiothorac Vasc Anesth. 1989;3:425–32.

    Article  CAS  Google Scholar 

  22. Miller RD, Roderick LL. Diuretic-induced hypokalaemia, pancuronium neuromuscular blockade and its antagonism by neostigmine. Br J Anaesth. 1978;50:541–4.

    Article  CAS  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention. Vital signs. 2011. www.cdc.gov/vitalsigns/asthma/index.html

  24. Warner DO, Warner MA, Barnes RD, et al. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996;85:460–7.

    Article  CAS  PubMed  Google Scholar 

  25. Kabalin CS, Yarnold PR, Grammer LC. Low complication rate of corticosteroid-treated asthmatics undergoing surgical procedures. Arch Intern Med. 1995;155:1379.

    Article  CAS  PubMed  Google Scholar 

  26. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941.

    Article  CAS  PubMed  Google Scholar 

  28. Wagner RL, White PF, Kan PB, et al. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984;310:1415.

    Article  CAS  PubMed  Google Scholar 

  29. Murray H, Marik PE. Etomidate for endotracheal intubation in sepsis: acknowledging the good while accepting the bad. Chest. 2005;127:707.

    Article  PubMed  Google Scholar 

  30. Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet. 1967;2:856.

    Article  CAS  PubMed  Google Scholar 

  31. Westerhof L, Van Ditmars MJ, Der Kinderen PJ, et al. Recovery of adrenocortical function during long-term treatment with corticosteroids. Br Med J. 1972;2:195.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143(12):1222–6.

    Article  CAS  PubMed  Google Scholar 

  33. Kakkar AK, Cohen AT, Tapson VF, ENDORSE Investigators, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg. 2010;251:330–8.

    Article  PubMed  Google Scholar 

  34. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292:1573–80.

    Article  CAS  PubMed  Google Scholar 

  35. Zambouri A. Preoperative evaluation and preparation for anesthesia and surgery. Hippokratia. 2007;11(1):13–21.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295.

    Google Scholar 

  37. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326S.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Horlocker TT, Wedel DJ, Schroeder DR, Rose SH, Elliott BA, McGregor DG, Wong GY. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80(2):303–9.

    CAS  PubMed  Google Scholar 

  39. Llau JV, Lopez-Forte C, Sapena L, Ferrandis R. Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol. 2009;26:181–7.

    Article  CAS  PubMed  Google Scholar 

  40. Smart S, Aragola S, et al. Antiplatelet agents and anesthesia. Contin Educ Anaesth Crit Care Pain. 2007;7(5):157–61.

    Article  Google Scholar 

  41. Horlocker T, Wedel D. Regional anesthesia in the anticoagulated patient: defining the risks (The second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28(3):172–97.

    PubMed  Google Scholar 

  42. Barar FS, Boakes AJ, Benedikter LB, Laurence DR, Prichard BN, Teoh PC. Interactions between catecholamines and tricyclic and monoamine oxidase inhibitor antidepressive agents in man. Br J Pharmacol. 1971;43(2):472P–3.

    CAS  PubMed Central  PubMed  Google Scholar 

  43. Stack CG, Rodgers P, Linter SP. Monoamine oxidase inhibitors and anesthesia. Br J Anaesth. 1988;60(2):222–7.

    Google Scholar 

  44. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and reconsideration of mechanisms. J Clin Psychiatry. 2010;71:1565–75.

    Article  PubMed  Google Scholar 

  45. Kurt AS. Lithium-induced nephrogenic diabetes insipidus. J Am Board Fam Pract. 1999;12:43–7.

    Article  Google Scholar 

  46. Henry C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences. J Psychiatry Neurosci. 2002;27(2):104–7.

    PubMed Central  PubMed  Google Scholar 

  47. Hill GE, Wong KC, Hodges MR. Lithium carbonate and neuromuscular blocking agents. Anesthesiology. 1977;46(2):122–6.

    Google Scholar 

  48. Kim, et al. Effects of valproic acid and magnesium sulphate on rocuronium requirement in patients undergoing craniotomy for cerebrovascular surgery. Br J Anesth. 2012;109:407–12.

    Article  CAS  Google Scholar 

  49. Miller R. Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I. Curr Neuropharmacol. 2009;7(4):302–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Glassman AH, Bigger Jr JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158(11):1774–82.

    Article  CAS  PubMed  Google Scholar 

  52. Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis. 2003;45(5):415–27.

    Article  CAS  PubMed  Google Scholar 

  53. Amore M, Zazzeri N. Neuroleptic malignant syndrome after neuroleptic discontinuation. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:1323–34.

    Article  CAS  PubMed  Google Scholar 

  54. Rozen D, DeGaetano NP. Perioperative management of opioid-tolerant chronic pain patients. J Opioid Manag. 2006;2:353–63.

    PubMed  Google Scholar 

  55. Lewis N, Williams J. Acute pain management in patients receiving opioids for chronic and cancer pain. Contin Educ Anesth, Crit Care Pain. 2005;5:127–9.

    Article  Google Scholar 

  56. Collett B-J. Opioid tolerance: the clinical perspective. Br J Anaesth. 1998;81:58–68.

    Article  CAS  PubMed  Google Scholar 

  57. Kaye AD, Clarke R, Sabar R, Kaye AM. Herbal medications survey. J Clin Anesth. 2000;12:468–71.

    Article  CAS  PubMed  Google Scholar 

  58. Trichopolos D, Kalandidi A, Sparros L, Macmahon B. Lung cancer and passive smoking. Int J Cancer. 1981;27:1–4.

    Article  Google Scholar 

  59. Katz LN. Cigarette smoking and cardiovascular diseases: report by the American Heart Association. Circulation 1960;22:160–6.

    Google Scholar 

  60. Hung J, Lam J, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation. 1995;92:2432–6.

    Article  CAS  PubMed  Google Scholar 

  61. Vassallo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care Med. 2008;29(6):643–50.

    Article  PubMed  Google Scholar 

  62. Whalen F, Sprung J, Burkle CM, Schroeder DR, Warner DO. Recent smoking behavior and postoperative nausea and vomiting. Anesth Analg. 2006;103(1):70–5.

    Article  PubMed  Google Scholar 

  63. Rodrigo C. The effects of cigarette smoking on anesthesia. Anesth Prog. 2000;47(4):143–50.

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Westerdahl E, Lindmark B, Eriksson T, Friberg O, Hedenstierna G, Tenling A. Deep-breathing exercises reduce atelectasis and improve pulmonary function after coronary artery bypass surgery. Chest J. 2005;128(5):3482–8.

    Article  Google Scholar 

  65. Leslie K, Sessler DI, Bjorksten AR, Moayeri A. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg. 1995;80:1007–14.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela Vick MD .

Editor information

Editors and Affiliations

Chemical Structures

Chemical Structures

Chemical Structure 5.1
figure 1

Propofol

Chemical Structure 5.2
figure 2

Rocuronium bromide

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Vick, A., Vydyanathan, A., Safi, T., Gritsenko, K. (2015). Perioperative Considerations in Pharmacology. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8948-1_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8947-4

  • Online ISBN: 978-1-4614-8948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics